Understanding the action mechanisms of metformin in the gastrointestinal tract
Frontiers in Pharmacology · 28.03.2024 · 15
DOI: 10.3389/fphar.2024.1347047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.03.2024. Verfasst von Meihui Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, National Institute of Pathogen Biology, Chinese Academy of Medical Scien…. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metformin is the initial medication recommended for the treatment of type 2 diabetes mellitus (T2DM). In addition to diabetes treatment, the function of metformin also can be anti-aging, antiviral, and anti-inflammatory. Nevertheless, further exploration is required to fully understand its mode of operation. Historically, the liver has been acknowledged as the main location where metformin reduces glucose levels, however, there is increasing evidence suggesting that the gastrointestinal tract also plays a significant role in its action. In the gastrointestinal tract, metformin effects glucose uptake and absorption, increases glucagon-like peptide-1 (GLP-1) secretion, alters the composition and structure of the gut microbiota, and modulates the immune response. However, the side effects of it cannot be ignored such as gastrointestinal distress in patients. This review outlines the impact of metformin on the digestive system and explores potential explanations for variations in metformin effectiveness and adverse effects like gastrointestinal discomfort.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- College of Forensic Medicine, Hebei Key Laboratory of Forensic Medicine, Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Medical University, Shijiazhuang, China.
- NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Pathogen Biology, Institute of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Zitieren
APA
Cheng, M., Ren, L., Jia, X., Wang, J., & Cong, B. (2024). Understanding the action mechanisms of metformin in the gastrointestinal tract. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1347047
Vancouver
Cheng M, Ren L, Jia X, Wang J, Cong B. Understanding the action mechanisms of metformin in the gastrointestinal tract. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1347047
BibTeX
@article{Cheng2024,
author = {Cheng, Meihui and Ren, Lili and Jia, Xianxian and Wang, Jianwei and Cong, Bin},
title = {Understanding the action mechanisms of metformin in the gastrointestinal tract},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1347047}
}
EUVIMED